ArticleCell reports. Medicine2024

Phase 1a study of ESG401, a Trop2 antibody-drug conjugate, in patients with locally advanced/metastatic solid tumors.

Jiani Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.